Handok Inc. (KOSE:A002390) agreed to acquire an additional 16% stake in Genexine, Inc. (KOSDAQ:A095700) for KRW 25.8 billion on March 24, 2014. Under the terms of the transaction, Handok will acquire 1 million shares in the transaction to hold a total of 2.2 million shares in Genexine post transaction. Expected transaction settlement date is March 24, 2014.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,670 KRW | -3.19% | -8.76% | -32.63% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.63% | 200M | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- A095700 Stock
- News Genexine, Inc.
- Handok Inc. agreed to acquire an additional 16% stake in Genexine, Inc. for KRW 25.8 billion.